Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses the need and importance of The Doctor’s Channel, and applauds its unique concept. For the Bill Crounse,…
Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses patients and their increasing use of the internet for health information. For the Bill Crounse, MD blog…
Bill Crounse, MD, Senior Director for Worldwide Health, Microsoft Corporation, discusses how Health Vault refines the experience of managing personal health for consumers. For the Bill Crounse, MD…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses lung cancer in…
A study presented at the American Association for Cancer Research meeting showed progression of androgen-independent prostate cancer was significantly inhibited in mice by a combination of atorvastatin (Lipitor)…
Rituximab failed to meet the primary endpoint of stemming the progression of primary-progressive multiple sclerosis (PPMS) in a Phase II/III trial. From Our Partners at VerusMed verusmed.com Sponsored…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses treatment therapies and…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his website OncTalk,…
At the American Academy of Neurology meeting, researchers gave final results of the phase III PRECISE trial of glatiramer acetate (Copaxone), which delayed the onset of clinically confirmed…
Vineet Arora, MD, MA, Assistant Professor of Medicine, Assistant Dean of Curricular Innovation of Pritzker School of Medicine, and Associate Program Director of the Internal Medicine Residency Program,…